Jim Stott

967 total citations
24 papers, 787 citations indexed

About

Jim Stott is a scholar working on Virology, Infectious Diseases and Immunology. According to data from OpenAlex, Jim Stott has authored 24 papers receiving a total of 787 indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Virology, 8 papers in Infectious Diseases and 8 papers in Immunology. Recurrent topics in Jim Stott's work include HIV Research and Treatment (18 papers), HIV/AIDS Research and Interventions (8 papers) and Immune Cell Function and Interaction (6 papers). Jim Stott is often cited by papers focused on HIV Research and Treatment (18 papers), HIV/AIDS Research and Interventions (8 papers) and Immune Cell Function and Interaction (6 papers). Jim Stott collaborates with scholars based in United Kingdom, United States and Japan. Jim Stott's co-authors include Neil Almond, Frances Gotch, Richard Stebbings, Karen A. Kent, Barry Walker, Andrew J. McMichael, Michael J. Dennis, T. Corcoran, Tao Dong and Martin Cranage and has published in prestigious journals such as Nature, Nature Medicine and The Journal of Experimental Medicine.

In The Last Decade

Jim Stott

23 papers receiving 753 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jim Stott United Kingdom 15 598 388 258 208 142 24 787
Sachio Tokiyoshi Japan 11 499 0.8× 245 0.6× 283 1.1× 228 1.1× 180 1.3× 20 770
Melanie West United States 10 659 1.1× 311 0.8× 363 1.4× 264 1.3× 197 1.4× 12 928
B. J. Potts United States 9 625 1.0× 248 0.6× 173 0.7× 414 2.0× 213 1.5× 14 850
Harold Legg United States 15 478 0.8× 306 0.8× 249 1.0× 386 1.9× 178 1.3× 21 790
Mike Piatak United States 12 377 0.6× 230 0.6× 350 1.4× 212 1.0× 164 1.2× 13 809
W. Gerard Robey United States 10 714 1.2× 405 1.0× 182 0.7× 344 1.7× 235 1.7× 14 925
Innocent Mboudjeka United States 18 749 1.3× 371 1.0× 252 1.0× 402 1.9× 269 1.9× 22 1.0k
Florence Buseyne France 21 1.0k 1.7× 869 2.2× 399 1.5× 307 1.5× 228 1.6× 56 1.4k
Harvey Holmes United Kingdom 14 365 0.6× 113 0.3× 279 1.1× 443 2.1× 102 0.7× 28 738
Jason T. Weinfurter United States 13 349 0.6× 489 1.3× 474 1.8× 192 0.9× 126 0.9× 17 885

Countries citing papers authored by Jim Stott

Since Specialization
Citations

This map shows the geographic impact of Jim Stott's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jim Stott with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jim Stott more than expected).

Fields of papers citing papers by Jim Stott

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jim Stott. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jim Stott. The network helps show where Jim Stott may publish in the future.

Co-authorship network of co-authors of Jim Stott

This figure shows the co-authorship network connecting the top 25 collaborators of Jim Stott. A scholar is included among the top collaborators of Jim Stott based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jim Stott. Jim Stott is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Berry, Neil, Claire Ham, Sean F. Clarke, et al.. (2015). Live attenuated simian immunodeficiency virus vaccination confers superinfection resistance against macrophage-tropic and neurovirulent wild-type SIV challenge. Journal of General Virology. 96(7). 1918–1929. 5 indexed citations
2.
Stott, Jim, et al.. (2012). Assessing the Magnitude and Consequences of Reservoir Souring. Journal of Petroleum Technology. 64(5). 76–79. 2 indexed citations
4.
Stebbings, Richard, Neil Berry, Herman Waldmann, et al.. (2005). CD8 + Lymphocytes Do Not Mediate Protection against Acute Superinfection 20 Days after Vaccination with a Live Attenuated Simian Immunodeficiency Virus. Journal of Virology. 79(19). 12264–12272. 29 indexed citations
5.
Stebbings, Richard, Neil Berry, Jim Stott, et al.. (2004). Vaccination with live attenuated simian immunodeficiency virus for 21 days protects against superinfection. Virology. 330(1). 249–260. 27 indexed citations
6.
Stott, Jim, et al.. (2002). Construction Partnering: Can These Protocols Build a Stronger Labor-Management Community?. Pepperdine Digital Commons (Pepperdine University). 2(3). 6. 1 indexed citations
7.
Wade-Evans, A.M., Jim Stott, Tomáš Hanke, et al.. (2001). Specific Proliferative T Cell Responses and Antibodies Elicited by Vaccination with Simian Immunodeficiency Virus Nef Do Not Confer Protection against Virus Challenge. AIDS Research and Human Retroviruses. 17(16). 1517–1526. 6 indexed citations
8.
Silvera, Peter, et al.. (2001). Mechanisms of protection induced by live attenuated simian immunodeficiency virus. Journal of Medical Primatology. 30(1). 1–13. 15 indexed citations
9.
Weber, Jonathan, Andrew Nunn, Tim O’Connor, et al.. (2001). `Chemical condoms’ for the prevention of HIV infection: evaluation of novel agents against SHIV89.6PDin vitro and in vivo. AIDS. 15(12). 1563–1568. 64 indexed citations
10.
Stebbings, Richard, Jim Stott, Neil Almond, et al.. (1998). Mechanisms of Protection Induced by Attenuated Simian Immunodeficiency Virus II. Lymphocyte Depletion Does Not Abrogate Protection. AIDS Research and Human Retroviruses. 14(13). 1187–1198. 31 indexed citations
11.
Stott, Jim, et al.. (1998). Candidate vaccines protect macaques against primate immunodeficiency viruses.. PubMed. 14 Suppl 3. S265–70. 10 indexed citations
12.
Mooij, Petra, M. van der Kolk, Willy Bogers, et al.. (1998). A clinically relevant HIV-1 subunit vaccine protects rhesus macaques from in vivo passaged simian–human immunodeficiency virus infection. AIDS. 12(5). F15–F22. 54 indexed citations
13.
Bogers, Willy, Rob Dubbes, Peter ten Haaft, et al.. (1997). Comparison ofin Vitroandin VivoInfectivity of Different Clade B HIV-1 Envelope Chimeric Simian/Human Immunodeficiency Viruses inMacaca mulatta. Virology. 236(1). 110–117. 21 indexed citations
14.
Polyanskaya, Natasha, S. Sharpe, Jill Banks, et al.. (1997). Anti-Major Histocompatibility Complex Antibody Responses to Simian B Cells Do Not Protect Macaques against SIV mac Infection. AIDS Research and Human Retroviruses. 13(11). 923–931. 24 indexed citations
15.
Gallimore, Awen, Martin Cranage, Nicola Cook, et al.. (1995). Early suppression of SIV replication by CD8+ nef-specific cytotoxic T cells in vaccinated macaques. Nature Medicine. 1(11). 1167–1173. 156 indexed citations
16.
Doyle, Carl, et al.. (1995). Regions required for CD4 binding in the external glycoprotein gp120 of simian immunodeficiency virus. Journal of Virology. 69(2). 1256–1260. 22 indexed citations
17.
Javaherian, Kashi, A J Langlois, David C. Montefiori, et al.. (1994). Studies of the conformation-dependent neutralizing epitopes of simian immunodeficiency virus envelope protein. Journal of Virology. 68(4). 2624–2631. 31 indexed citations
18.
Cranage, Martin, Jim Stott, Kingston H. G. Mills, et al.. (1992). Vaccine Studies With the 32 H Reisolate of SIV mac251 : An Overview. AIDS Research and Human Retroviruses. 8(8). 1479–1481. 15 indexed citations
19.
Stott, Jim, et al.. (1985). Potency and efficacy of inactivated bluetongue virus vaccines.. PubMed. 178. 649–52. 7 indexed citations
20.
Brown, F., J. F. E. Newman, Jim Stott, et al.. (1974). Poly(C) in animal viral RNAs. Nature. 251(5473). 342–344. 63 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026